H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 16.1% of adults in Paterson have diagnosed diabetes — 4.1 points above the U.S. 12% figure. Census population 159,732. New Jersey Medicare wound biologics: Novitas Solutions (JL). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Paterson clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Paterson storefront.
361 HCT/P Compliant Tissue Products in Paterson, NJ for clinics & physicians. Exclusively 361 HCT/P compli… Compliance support & pricing — contact Hawk Medical.
CDC PLACES (2023, crude) estimates 16.1% of adults in Paterson have diagnosed diabetes — 4.1 points above the U.S. 12% figure. Census city-proper population is 159,732. If you are adding 361 hctp compliant products, start with that epidemiology and with Novitas Solutions (JL) — not with a “near me” clinic listing. Hawk Medical ships nationwide; Joe Bradley’s own practice uses the same product classes.
National 361 HCT/P Compliant Tissue Products notes (how the product actually works)CDC PLACES (2023, crude) estimates 16.1% of adults in Paterson have diagnosed diabetes — 4.1 points above the U.S. 12% figure. Adult obesity in Paterson is 37.5% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 20% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: JL / Novitas Solutions, sibling states DC, DE, MD, PA. New Jersey Department of Health is the public-health home. We will not mash those grains into a fake “demand score.”
If you already buy 361 hctp compliant products elsewhere, use this page as a check: homologous-use language, current Novitas Solutions article IDs, and PLACES 16.1% diabetes as the epidemiologic floor. If that is how you already practice, the catalog will fit.
CDC PLACES (2023, crude prevalence) estimates 16.1% of adults — 4.1 points above the U.S. 12% figure. Obesity is 37.5%; arthritis is 20%. That is place-level BRFSS modeling, not a clinic census and not a Paterson trial.
Yes. Tissue products come from FDA-registered banks with donor screening and lot traceability. Your receiving SOP should file IFU, lot, and indication with the chart. That packet is what JL reviewers and surveyors expect — not a brochure.
No. Organization schema on this site does not publish a fake aggregateRating. Testimonials on marketing pages are not assigned to Paterson as local reviews.
No. They are B2B distribution pages for licensed providers. Patients in Paterson should speak with their clinician, not use a distributor URL as care instructions.
If you operate in New Jersey and another MAC state, say it on the first call. JL will not port 1:1. We would rather split utilization than watch a sister clinic copy Paterson tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Paterson, NJ.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Paterson is JL geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Paterson — 4.1 points above the U.S. 12% figure. Planning input, not an outcomes claim.
New Jersey Part B wound biologics follow this contractor (siblings: DC, DE, MD, PA). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Paterson. Useful for joint-program math; still needs a diagnosis and privileging.
No Paterson storefront. Joe Bradley is an active practice owner. 361 hctp compliant products stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.